Congratulations to the new NOISE Principal Investigators
The NOISE team congratulates NOISE Study co-founder Dr. James Henry on his retirement after a long and successful career. Dr. Henry is recognized worldwide as a distinguished tinnitus researcher and scientist, and for his work as co-developer of the Progressive Tinnitus Management approach to supporting individuals with tinnitus.
We are excited to announce that the new NOISE Study Principal investigator is Dr. Kathleen Carlson, PhD and the new Co-Principal Investigator is Dr. Kelly Reavis, PhD. With their leadership, the NOISE Study will continue to answer important research questions on military service and hearing health outcomes.
NOISE Study receives MHSRS award for Outstanding Research Accomplishment
Image retrieved from: https://mhsrs.health.mil/SitePages/Home.aspx below ‘2022 MHSRS Award Winners’
We are honored to announce that the NOISE Study has received a 2022 Military Health Service Research Symposium (MHSRS) award for Outstanding Research Accomplishment (Team). This award recognizes outstanding research contributions by a team of research scientists, focusing on significant accomplishments of high impact achieved during the past year.
MHSRS is the Department of Defense’s most prominent scientific meeting. This event focuses on military research and development relevant to the medical needs of military Service members.
New NOISE Study site to enroll participants in Southern California
The NOISE Study team is excited to announce the addition of a third NOISE study site in Southern California. The San Diego area, home to multiple Navy and Marine Corps bases, was selected for the new site to improve representation across military branches in the study sample.
This site is made possible by a Department of Defense Joint Warfighter Medical Research Program award. A research audiologist and research coordinator located in the San Diego area have joined the NOISE Study team, and the site also receives support from a regional research administrator and DoD clinician collaborators. Data collection is expected to begin in fall of 2022.